Loading insider details...
Latest Form 4 (Jun 4, 2026): Grant/Award of 20,100 AVTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 20,100 | n/a |
| Mar 31, 2026 | Avalo Therapeutics, Inc. (AVTX) | Exercise/Conversion | 3,166 | n/a |
| Oct 28, 2025 | Tourmaline Bio, Inc. (TRML) | Tender of Shares | 88,281 | n/a |
| Oct 24, 2025 | Tourmaline Bio, Inc. (TRML) | Gift | 5,000 | n/a |
| Sep 9, 2025 | Tourmaline Bio, Inc. (TRML) | Exercise/Conversion | 37,890 | $4.9K |
| Jun 18, 2025 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 20,100 | n/a |
| Jun 6, 2025 | Tourmaline Bio, Inc. (TRML) | Grant/Award | 16,800 | n/a |
| Apr 1, 2025 | Avalo Therapeutics, Inc. (AVTX) | Exercise/Conversion | 3,167 | n/a |
| Aug 14, 2024 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 24,600 | n/a |
| Jun 7, 2024 | Tourmaline Bio, Inc. (TRML) | Grant/Award | 10,000 | n/a |